glp-1 weight loss drug news today october 2025 Alarming rise in overdoses New research shows that while
Description
If you develop pulsatile tinnitus, it should be evaluated by a doctor
Alzheimers disease drug development pipeline: 2024
Osteoporosis in anorexia nervosa
Compared with SGLT-2 inhibitors, the GLP-1 receptor agonist-SGLT-2 inhibitor combination was associated with a 29% lower risk of major adverse cardiovascular events (7.6 v 10.7 events per 1000 person years
It is important to note that an impact of the Inflation Reduction Act is that small molecule therapeutics may continue to be deprioritized in favor of biologics, so development of oral biologics may (unfortunately) be more compelling for companies in this context
"So there are many possible reasons we're seeing signals that the trials may have missed." Overlooked effects Nearly half of the users reported one or more side effects
